Easy-to-use web-based database enables users to generate custom reports based upon any combination of these variables: Brand, Therapeutic area, Company, Country and Time period.

1. PharmaForce International Inc.
Insightful Intelligence with a Global Reach
Global Headquarters
2645 Perkiomen Avenue • Reading, PA 19606 • (610) 370-5640 • Fax (610) 370-5641 • www.pharmaforce.biz
Global Pharmaceutical Sales Force
Deployment Analyzer
Europe, India, Japan, Latin America
and the United States

2. 1

3. About PharmaForce International
• Specialists in multi-client (syndicated) and proprietary sales, marketing and medical
benchmarking and market research for the pharmaceutical and biotech industries
• Global leaders in identifying “everything and anything” that pharmaceutical companies
want to know about the operations of their competitors and perspectives of their
customers
• Multi-lingual staff with direct experience in the pharmaceutical industry and business
intelligence
– Hundreds of years of combined industry experience as District Managers, Product
Managers, Medical Information Specialists, Market Research Directors, Training
Managers and Country Business Unit Directors
Copyright 2013 by PharmaForce International R E A D I N G, P A
2
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

4. Field-Tested Primary Source Research Approach
More than 90% of the information for any project is derived from one-on-one interviews
with individuals in the industry, including current and former employees of the target
organizations
– Interviewers draw upon their knowledge and personal experiences in the industry to
form a common bond with interview targets and engage in peer-to-peer discussions
about topics of common interest
– Supplemented with exhaustive searches of all relevant electronic and printed
databases, including PharmaForce’s proprietary databases developed over the past
decade
Database of qualified contacts in the pharmaceutical industry exceeds 45,000
– Includes personnel in almost every sales and marketing function from sales
representatives to senior management
– Systematic, ongoing process to add new contacts
Copyright 2013 by PharmaForce International R E A D I N G, P A
3
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

5. Field-Tested Primary Source Research Approach
(cont’d)
Typically, 25% of interviewees participate willingly, while another 25% refuse to
participate
– Strong interviewing skills come into play with the middle 50% as key partial pieces of
data are culled from their limited responses
– Ability to trade data on previously-researched companies dramatically increases the
level of cooperation
One-on-one discussions with multiple knowledgeable sources result in verification of
data
– Outliers are quickly identified and assimilated through more interviews
Copyright 2013 by PharmaForce International R E A D I N G, P A
4
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES

6. Triangulation of data from contacts who are customers, suppliers and target company
employees results in multiple confirmations of findings from all possible perspectives
– Previous research experience on the topics allows for the widest possible knowledge
base of the target deliverables and key resources
Copyright 2013 by PharmaForce International R E A D I N G, P A
5
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES
Field-Tested Primary Source Research Approach
(cont’d)

7. About the Global Deployment Analyzer
Based on client requests for timely and accurate deployment and marketed product
information, PharmaForce International developed the Global Pharmaceutical Sales
Force Deployment Analyzer
– Powerful web-based database program that covers the deployment of leading
pharmaceutical companies’ sales forces in the United States, Europe, India, Japan
and selected Latin American countries
– Easy-to-use database contains up-to-date information on leading companies in
Europe, India, Japan , Argentina, Brazil , Mexico and the United States
– Continuously-updated database
 As PharmaForce receives new or revised data on each of the target companies,
the new data will be immediately added to the database
 No waiting for the next quarterly or yearly installment
Copyright 2013 by PharmaForce International R E A D I N G, P A
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES
6

8. About the Global Deployment Analyzer (cont’d)
Available database programs
– European Deployment Analyzer database
 Introduced in 2003
 Information about 25 leading pharmaceutical companies’ sales forces
– Japan Deployment Analyzer database
 Launched in 2009
 Information about 26 leading pharmaceutical companies’ sales forces
– U.S. Deployment Analyzer database
 Introduced in 2008
 Information about over 60 leading pharmaceutical companies’ sales forces
Copyright 2013 by PharmaForce International R E A D I N G, P A
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES
7

9. About the Global Deployment Analyzer (cont’d)
– India Deployment Analyzer database
 Introduced in 2012
 Information about 12 leading pharmaceutical companies’ sales forces
– Latin America Deployment Analyzer database
 Introduced in 2012
 Information about 13 companies in Argentina, Brazil and Mexico
Copyright 2013 by PharmaForce International R E A D I N G, P A
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES
8

10. About the Global Deployment Analyzer (cont’d)
Easy-to-use web-based database enables users to generate custom reports based upon
any combination of the following variables:
– Brand
– Therapeutic area
– Company
– Country
– Time period
Copyright 2013 by PharmaForce International R E A D I N G, P A
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES
9

11. About the Global Deployment Analyzer (cont’d)
Data available in the Deployment Analyzer includes:
– Total number of company Sales Representatives deployed by sales group:
 Primary Care
 Specialty/Hospital
– Number of Sales Representatives by therapeutic area
– Number of Sales Representatives (Full-Time Equivalents/FTEs) supporting individual
brands
 Based on “relative effort” reported by company personnel in interviews
– Product priorities by each:
 Sales group
 Sales force (U.S. only)
 Therapeutic area
Copyright 2013 by PharmaForce International R E A D I N G, P A
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES
10

12. About the Global Deployment Analyzer (cont’d)
Average salaries and bonuses
Data available in the U.S. and Japan Deployment Analyzers also includes:
– Total number of District Managers, Regional Managers and other sales management
by group/division as defined by the target company
– Sales group organizational structures
– Call Reach & Frequency Analysis
Copyright 2013 by PharmaForce International R E A D I N G, P A
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES
11

13. Comprehensive List of Therapeutic Areas Covered in
the Database
Anti-Infectives (includes antibiotics, anti-fungals anti-virals)
Cardiovascular
CNS, Pain and Anesthesia
Dermatology
Endocrinology and Metabolic Disorders
Gastrointestinal
Gynecology/Women’s Health
Nephrology and Transplantation
Oncology and Hematology
Ophthalmology
Respiratory and Allergy
Rheumatology, Bone and Inflammation
Urology
Vaccines
Other
Copyright 2013 by PharmaForce International R E A D I N G, P A
GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES
12

14. 13

15. 10 Target Countries
Copyright 2013 by PharmaForce International R E A D I N G, P A
14
Austria
Belgium
France
Germany
Italy
Netherlands
Spain
Sweden
Switzerland
United Kingdom
EUROPE DEPLOYMENT ANALYZER

16. Target Companies
Copyright 2013 by PharmaForce International R E A D I N G, P A
1. AbbVie (incl. former Solvay)
2. Amgen
3. Astellas
4. AstraZeneca
5. Bayer
6. Biogen Idec
7. Boehringer Ingelheim
8. Bristol-Myers Squibb
9. Celgene
10. Daiichi-Sankyo
11. Eisai
12. Eli Lilly
13. GlaxoSmithKline
14. Janssen
15. Lundbeck
16. Merck Serono
17. Merck Sharp & Dohme (incl. former Schering-Plough)
18. Novartis
19. Novo Nordisk
20. Pfizer
21. Roche
22. Sanofi (incl. former Genzyme)
23. Takeda (incl. former Nycomed)
24. Teva (incl. former Cephalon)
25. UCB
15
EUROPE DEPLOYMENT ANALYZER

17. 16

18. Target Companies
Copyright 2013 by PharmaForce International R E A D I N G, P A
1. AbbVie
2. Biocon
3. Cipla
4. Dr. Reddy Labs
5. Eli Lilly
6. Fresenius Kabi
7. Lupin
8. Mankind
9. Novartis
10. Pfizer
11. Sanofi
12. Sun
INDIA DEPLOYMENT ANALYZER
17

19. 18

20. Target Companies
Copyright 2013 by PharmaForce International R E A D I N G, P A
1. AbbVie
2. Astellas
3. AstraZeneca
4. Banyu (incl. former Schering-Plough)
5. Bayer
6. Bristol-Myers Squibb
7. Chugai
8. Daiichi-Sankyo
9. Dainippon Sumitomo
10. Eisai
11. Eli Lilly
12. GlaxoSmithKline
13. Janssen
14. Kyowa Hakko Kirin
15. Mitsubishi Tanabe
16. Nippon Boehringer Ingelheim
17. Nippon Kayaku
18. Novartis
19. Otsuka
20. Pfizer
21. Sanofi
22. Shionogi
23. Taiho
24. Taisho Toyama
25. Takeda
26. Yakult Honsha
JAPAN DEPLOYMENT ANALYZER
19

21. 20

22. Target Companies
Copyright 2013 by PharmaForce International R E A D I N G, P A
1. AstraZeneca
2. Bayer
3. Boehringer Ingelheim
4. Bristol-Myers Squibb
5. Eli Lilly
6. EMD Serono
7. Genentech/Roche
8. GlaxoSmithKline
9. Janssen
10. Merck
11. Novartis
12. Pfizer
13. Sanofi
LATIN AMERICA DEPLOYMENT ANALYZER
21

23. 22

24. Target Companies
Copyright 2013 by PharmaForce International R E A D I N G, P A
1. AbbVie
2. Abbott Medical Optics
3. Actavis (formerly Watson)
4. Actelion
5. Alcon (incl. Ciba Vision)
6. Alexion
7. Allergan
8. Allos
9. Amgen
10. Astellas (incl. OSI)
11. AstraZeneca
12. Auxilium
13. Bausch & Lomb (incl. former Ista)
14. Baxter
15. Bayer
16. Biogen Idec
17. Boehringer Ingelheim
18. Bristol-Myers Squibb (incl. former Amylin)
19. Celgene (incl. former Abraxis Bioscience)
20. Cooper Vision
21. Cubist
22. Daiichi-Sankyo
23. Eisai
24. Eli Lilly & Company
25. EMD Serono
26. Endo (incl. former Indevus)
27. Ferring
28. Forest Lab
29. Fougera Pharmaceutical
30. Galderma
31. Genentech/Roche
32. Gilead
33. GlaxoSmithKline (incl. former Stiefel)
34. Ipsen
U.S. DEPLOYMENT ANALYZER
23

25. Target Companies (cont’d)
Copyright 2013 by PharmaForce International R E A D I N G, P A
35. Iridex
36. J&J Ophthalmics/Vistakon
37. Janssen Biotech (formerly Centocor)
38. Janssen Pharmaceuticals
39. Meda
40. Merck (incl. former Schering-Plough and Inspire)
41. Merz
42. Novartis
43. Novo Nordisk
44. Onyx Pharmaceuticals
45. Otsuka
46. Pfizer (incl. former Wyeth and King)
47. Purdue
48. Regeneron
49. Sanofi (incl. former Genzyme)
50. Sanofi Pasteur
51. Shire
52. Sunovion (formerly Sepracor)
53. Spectrum (incl. former Allos)
54. Synergetics
55. Takeda (incl. former Millennium)
56. Teva (incl. former Cephalon)
57. UCB
58. Valeant (incl. former Medicis and Dermik)
59. ViiV Healthcare
60. United Therapeutics
61. Warner Chilcott
24
U.S. DEPLOYMENT ANALYZER

26. 25

27. Access to the Global Deployment Analyzer Database
Any employee of your organization globally may access the Deployment Analyzer at any
time, 24 hours a day
– Accessible from any computer in the world with Internet access
Access the Global Pharmaceutical Sales Force Deployment Analyzer online at
http://www.pharmaforce.biz/
Support
– When logged into the database, pausing the cursor over a search button will
activate a description of the search function
– Visit the FAQ section in the database for questions about our terminology and
methodology
Copyright 2013 by PharmaForce International R E A D I N G, P A
DATABASE ACCESS
26